For Researchers

AFTD supports scientists at all career stages in advancing the understanding of FTD biology and disease mechanisms, exploring diagnostic and treatment approaches, and developing assistive technologies to enhance daily living for individuals with FTD.

Translational Research

• Accelerating Drug Discovery for FTD 
• ADDF Diagnostics Accelerator 
• FTD Biomarkers Initiative
• Digital Assessment Tools for FTD and ALS
• Target ALS Partnership 
• The Treat FTD Fund for Clinical Trials

Pilot Grants

• Pathways for Hope Pilot Grant
• Well-Being in FTD Pilot Grant

Holloway Fellowships

• Clinical Research Training Scholarship
• Holloway Postdoctoral Fellowship

Through various grant programs, AFTD awards millions in grants for basic and clinical research – $3 million during our most recent fiscal year alone.

View Active Awards
View Previous Grant Recipients

• FTD Research Roundtable  - a collaborative, precompetitive forum where biopharmaceutical companies engage with academia, government agencies, and advocacy groups to enhance FTD clinical trial outcomes.

• Holloway Summit - an annual meeting of experts dedicated to exploring a specific topic to advance FTD research.

The AFTD reserves a small budget for emergent sponsorship requests from external organizations for research-related events. If interested in requesting sponsorship, contact research@theaftd.org as early as possible in the funding year (July-July).

AFTD’s corporate partners are essential to sustaining our programs and deepening our engagement with the global FTD community. Together, we can achieve our shared vision of a world with compassionate care, effective support, and a future free of FTD. There are multiple opportunities for industry to partner with AFTD:  

Furthering Science 

• FTD Research Roundtable 
  The FTD Research Roundtable is a pre-competitive membership-based consortium where stakeholders from industry, academia, national and international regulatory agencies, and advocacy organizations convene to identify barriers, solutions, and best practices in FTD-focused drug development. 
• Grant Funding Opportunities 
  AFTD funds research from basic science to translational and clinical research. Organizations are eligible for funding from AFTD partnerships with the Alzheimer’s Drug Discovery Foundation, for mission-focused investments in preclinical drug discovery and early-stage clinical trials.  

Enabling Clinical Trials 

• Research Engagement Services 
  Companies working to develop therapies can partner with AFTD to learn more about the lived experience from those affected by FTD through initiatives such as learning sessions, focus groups, and advisory panels.  
• FTD Disorders Registry 
  An affiliated non-profit co-founded by AFTD and the Bluefield Project, the FTD Disorders Registry serves as a direct-to-participant resource for study recruitment and quantified self-report data on FTD disorders. The Registry also empowers people to make informed decisions about research participation. AFTD and the Registry work in partnership to utilize qualitative and quantitative patient experience data to inform research design and regulatory decision-making and can customize qualitative and quantitative data to answer questions about community values, priorities, and concerns of people directly impacted by FTD.  

To learn more about any of these opportunities, please email research@theaftd.org to begin a conversation. 

Corporate Sponsorship 

• General financial support from corporate sponsors is essential to furthering AFTD’s work across our mission pillars. To discuss sponsorship opportunities, please email development@theaftd.org. 

• FTD Disorders Registry  - an online database that collects information from those affected by all types of FTD.
• A Voice of the Patient Report - A summary of the lived experience of FTD collected during Externally Led Patient-Focused Drug Development meetings.
• Resource List for Researchers - This list is updated regularly. Email research@theaftd.org to suggest edits to this list.